Vaxcyte (PCVX) Interest Coverage Ratio (2019 - 2022)
Vaxcyte (PCVX) posted quarterly Interest Coverage Ratio of 93.3 for Q1 2026, down 59.15% year-over-year from 228.37 in Q1 2025, and down 4333.85% quarter-over-quarter from 2.1 in Q4 2025.
Powered by 
Analysis
Vaxcyte (PCVX) Interest Coverage Ratio (2019 - 2022) Analysis & Trends
Vaxcyte (PCVX) has reported Interest Coverage Ratio for 8 consecutive years, with 93.3 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 59.15% year-over-year to 93.3; the TTM figure through Mar 2026 stood at 674.14 (up 464.23% YoY), while the FY2025 annual figure was 1.43, down 12.11% from the prior year.
- Interest Coverage Ratio retreated to 93.3 in Q1 2026 per PCVX's latest filing, from 2.1 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 19.29 in Q4 2024 and bottomed at 93.3 in Q1 2026.
- Historically, Interest Coverage Ratio has averaged 14.2 across 5 years, with a median of 0.79 in 2022.
- On a YoY basis, Interest Coverage Ratio climbed as much as 94.7% in 2025 and fell as far as 18496.2% in 2025.
- Vaxcyte's Interest Coverage Ratio stood at 0.79 in 2022, then soared by 42.53% to 0.45 in 2023, then surged by 4348.62% to 19.29 in 2024, then slumped by 110.91% to 2.1 in 2025, then plunged by 4333.85% to 93.3 in 2026.
- Business Quant data shows PCVX's Interest Coverage Ratio at 93.3 in Q1 2026, 2.1 in Q4 2025, and 2.05 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Vaxcyte | 8.83 Bn | 8.83 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -23,943.00 |
| Jun 30, 2021 | -3,390.00 |
| Mar 31, 2020 | -3,942.29 |
| Dec 31, 2019 | -2,262.43 |
| Sep 30, 2019 | -1,348.89 |
| Jun 30, 2019 | -1,112.00 |